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Objectives. The effect of progression of left ventricular hyper. 
trophy on coronary artery dimensions was studied in patients with 
aortic valve disease. 
Methods. Cross·sectional area of the left and right coronary 
arteries was determined by quantitative coronary arteriography 
in 12 control subjects and in 10 patients with aortic valve disease 
at baseline and after a follow·up period of 66 months. 
Results. The cross·sectional area of the left coronary artery 
was larger in patients with aortic valve disease than in control 
subjects (left anterior descending artery 13 vs. 8 mm1, p < 0.001; 
left circumflex artery 13 vs. 6 mm2, p < 0.001). At the follow·up 
examination, cross·sectional area of the left coronary artery 
increased (left anterior descending artery 17 mm2, p < 0.01 vs. 
baseline; left circumflex artery 15 mm1, p < 0.01 vs. baseline). 
The cross· sectional area of the right coronary artery was not 
different in patients with aortic valve disease from that in control 
subjects. Left ventricular muscle mass was larger in patients with 
aortic valve disease both at baseline (269 g, p < 0.001) and after 
follow·up examination (339 g, p < 0.001) than in control subjects 
Several observations suggest that in the hypertrophied left 
ventricle there is increased vulnerability to ischemia (1,2). 
Although in the overloaded left ventricle coronary blood 
flow at rest is within normal limits (3), relative subendocar· 
dial hypoperfusion may develop during exercise or rapid 
cardiac pacing (1,2,4-6). It has been reported (7) that in 
patients with aortic valve disease and massive hypertrophy, 
left coronary artery size was enlarged preoperatively but 
decreased after valve replacement at an equal rate with the 
regression of left ventricular muscle mass. The purpose of 
the present study was to evaluate changes in coronary artery 
dimensions after progression of left ventricular hypertrophy 
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(136 g). The appropriateness of coronary artery size with respect 
to muscle mass was evaluated by normalizing cross·sectional area 
of the left coronary artery (left anterior descending plus left 
circumflex artery) per 100 g of left ventricular muscle mass 
(mm1/l00 g). This index was 10.9 mm2/100 g in control subjects, 
and decreased in subjects with aortic valve disease from 
10.3 mml/l00 g at baseline to 8.6 mm2/100 g at the follow·up 
measurement (p < 0.05 vs. control values). 
Conclusions. In patients with aortic valve disease, the progreso 
sion of left l'entricular hypertrophy is associated with an increase 
in left anterior descending and left circumflex coronary artery 
dimensions, whereas the size of the right coronary artery remains 
unchanged. Despite the enlargement of the left coronary artery, 
the cross·sectional area of the left coronary artery per 100 g of 
left ventricular muscle mass decreased. Hence, the increase in 
coronary artery size appears to be inadequate when the severity of 
left ventricular hypertrophy increases. 
(J Am CoU CardioI1992j20:1073-9) 
in patients with aortic valve disease who were not yet 
surgical candidates at the baseline cardiac catheterization. 
Methods 
Ten patients (mean age 51 ± 9 years, range 35 to 79) with 
aortic valve disease and normal coronary arteries were 
studied at baseline and after a follow.up period of 66 ± 36 
months (range 24 to 122) (mean age 56 ± 11 years, range 46 
to 85). Three patients had a bicuspid aortic valve. Twelve 
normal subjects (mean age 52 ± 8 years, range 38 to 65) 
evaluated for atypical chest pain served as control subjects. 
No control subject had a bicuspid valve. Body surface area 
did not differ between control subjects (1.85 ± 0.22 m2) and 
patients with aortic valve disease either at baseline (1.81 ± 
0.18 m2) or at follow·up study (1.82 ± 0.19 m2). Physical 
working capacity was determined by upright bicycle exer· 
cise testing at baseline and after the follow·up period. The 
maximal work load, which was achieved under steady state 
conditions (3·min steps), was expressed in percent of the 
agee, gender· and height·corrected normal value (8). 
Cardiac catheterization. Informed consent was obtained 
from all patients. The study protocol required selective 
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coronary arteriograms of high quality. These were obtained 
during diagnostic arteriography without any further exami-
nation for scientific purposes. Premedication consisted of 
10 mg of chlordiazepoxide given orally 1 h before cardiac 
catheterization. Vasoactive substances were withheld for 
24 h before catheterization. Left ventricular pressure was 
measured transseptaily with use of an 8.5F Brockenbrough 
catheter, whereas aortic pressure was determined through 
an 8F pigtail catheter introduced retrogradely from the right 
femoral artery. Pulmonary artery pressure was measured 
with a 7F Cournand catheter. Mean coronary perfusion 
pressure was calculated as mean aortic pressure minus mean 
right atrial pressure. Mean systolic pressure gradient and 
aortic valve area were calculated according to standard 
formula. Aortic regurgitation was assessed by thermodilu-
tion technique. 
Left ventricular angiograms were recorded simulta-
neously in the right and left anterior oblique projections at a 
filming rate of 50 frames/so Left ventricular volumes and 
ejection fraction were calculated with the area-length 
method (9). Left ventricular muscle mass was determined 
according to the method of Rackley et al. (10). 
Selective left and right coronary arteriography was car-
ried out from the right femoral artery (Judkins technique, 8F 
catheters) with multiple views for optimal visualization of 
the coronary arteries. Only patients with normal coronary 
arteries were included in the present analysis. 
Quantitative coronary arteriography. Quantitative evalu-
ation of coronary angiograms was performed with a semi-
automatic computer system (7,1 ,12). The system is based 
on a 35-mm film projector (Tagarno 35 eX), a slow-scan 
CCD-camera for image digitation and a computer work 
station (Apollo DN 3000) for image storage and processing. 
Contour detection was carried out with use of a geometric-
densitometric edge detection algorithm (12-14) (Fig. 1). The 
method of computerized analysis of coronary angiograms 
has been described elsewhere (7,11-17). 
The proximal cross-sectional area of the three major 
coronary vessels Cieft anterior descending, left circumflex 
and right coronary arteries) was measured from one to three 
end-diastolic cine frames. The proximal cross-sectional area 
of the left anterior descending and left circumflex arteries 
was defined as the vessel segment immediately beyond the 
bifurcation of the left main coronary artery over a length of 
approximately 1 cm. The computer traced this segment 
automatically and calculated the mean area over this seg-
ment. A circular lumen was assumed because only patients 
vvith normal coronary arteries were included (Fig. The 
proximal cross-sectional area of the right coronary artery 
was defined as the vessel segment 1 to 2 em distal to the 
coronary ostium. A vessel segment over a length of approx-
imately 1 em was analyzed, and the mean cross-sectional 
area was calculated as for the left coronary artery. For each 
vessel segment, three measurements in different projections 
were obtained and averaged to correct for biologic variations 
in coronary artery dimensions (1 ,17,18). Calibration was 
Figure 1. Representative coronary arteriogram of a patient with 
aortic stenosis at baseline (upper panel) and at the follow-up 
examination (lower panel). The contour of the left anterior descend-
ing coronary artery is automatically detected by the computer 
(dotted rectangle). At the follow-up examination an increase in left 
coronary artery cross-sectional area is evident (from 14.5 mm2 to 
16.6 mm2). 
performed automatically by using the proximal part ofthe 8F 
Judkins catheter as a scaling device (7,19). Left or right 
coronary artery dominance was evaluated according to 
standard criteria (20). No correlation between left domi-
nance and bicuspid valve was observed. As an index of the 
enlargement of the coronary arteries with respect to muscle 
mass, the cross-sectional area of the left coronary artery (left 
anterior descending plus left circumflex artery) per 100 g of 
left ventricular angiographic mass was calculated (7,21). 
Statistics. Statistical comparisons of hemodynamic and 
angiographic data among control subjects and baseline and 
follow-up measurements in patients with aortic valve disease 
were carried out by a one-way analysis of variance. When 
the analysis was significant, the Scheffe procedure was 
applied. The paired Student t test was used to compare 
baseline and follow-up data in patients aortic valve 
disease. The chi-square test was used to compare the type of 
coronary dominance between control subjects and patients 
with aortic valve disease. 
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Table 1. Hemodynamic and Angiographic Data. 
Control Patients With AVD (n = 10) 
SUbjects 
(n = 12) Baseline Follow-Up 
HR (beats/min) 70 ± 13 73 ± 8 80 ± 10 
LVSP (mm Hg) 114 ± 20 163 ± 2U 174 ± 22* 
L VEDP (mm Hg) 9±3 10 ± 3§ 15 ± 6t 
MPAP(mm Hg) 15 ± 3 19 ± 10 23 ± 10* 
MCPP(mmHg) 86 ± 8 102 ± 33 92 ± 15 
EF(%) 65 ± 4 63 ± 8 52 ± 1U 
EDV (ml) 137 ± 28 223 ± 1St 283 ± 115:j:,§ 
LMM (g) 136 ± 30 269 ± 60~ 339 ± 73t.!1 
*p < 0.05, tp < 0.01, ~p < 0.001 versus control values. §p < 0.01, lip < 
0.001 versus baseline measurements in patients with aortic valve disease. 
AVD = aortic valve disease; EDV = end-diastolic volume; EF = ejection 
fraction; HR = heart rate; LMM = left ventricular mass; L VEDP = left 
ventricular end-diastolic pressure; L VSP = left ventricular systolic pressure; 
MCPP = mean coronary perfusion pressure; MPAP = mean pulmonary artery 
pressure. 
Results 
Five patients had pure or predominant aortic stenosis 
(mean systolic pressure gradient 41 mm Hg [range 25 to 61]; 
aortic valve area 1.08 cm2 [range 0.9 to 1.5]) and five had 
pure or predominant aortic regurgitation (regurgitant frac-
tion 29%, range 21% to 37%). In patients with aortic steno-
sis, mean systolic pressure gradient was 69 mm Hg (range 
30 to 90) (p < 0.01 vs. baseline) and aortic valve area was 
0.6 cm2 (range 0.45 to 0.98) (p < 0.01 vs. baseline) at the 
follow-up examination, whereas regurgitant fraction was 
minimal. In patients with aortic regurgitation, mean regur-
gitant fraction was 54% (35% to 65%) (p < 0.01 vs. baseline) 
at the follow-up examination. Functional classification ac-
cording to the New York Heart Association was significantly 
higher at the follow-up evaluation than at baseline (2.43 vs. 
1.25, respectively, p < 0.(01) in both aortic stenosis and 
regurgitation. Physical working capacity was comparable to 
control values (97 ± 15%) in patients with aortic valve 
disease at baseline (82 ± 18%) but was decreased (p < 0.01) 
at the follow-up evaluation (56 ± 22%). 
Hemodynamic and angiographic data (Table 1). All pa-
tients were in sinus rhythm. Heart rate was similar in all 
three groups. Left ventricular peak systolic pressure was 
significantly higher in patients with aortic valve disease than 
in control subjects both at baseline and at follow-up exami-
nation. Left ventricular end-diastolic pressure was signifi-
cantly higher in patients with aortic valve disease at 
follow-up than at baseline or than in control subjects, 
whereas mean pulmonary artery pressure was higher in 
patients with aortic valve disease at follow-up than in control 
subjects. Mean coronary perfusion pressure was similar in 
control subjects and in patients with aortic valve disease 
both at baseline and follow-up. Ejection fraction was com-
parable in control subjects and in patients with aortic valve 
disease at baseline; however, it decreased significantly at the 
follow-up examination when compared with both baseline 
Table 2. Quantitative Coronary Arteriographic Data 
Control Patients With AVD (n = 10) 
Subjects 
(n = 12) Baseline Follow-Up 
CSALAD (mm2) 7.8 ± 3.6 13.3 ± 2.5~ 16.9 ± 4.5§ 
CSALc• (mm2) 6.3 ± 3.4 12.9 ± 5.3~ 14.9 ± 3.3§ 
CSARCA (mm2) 9.0 ± 4.7 10.4 ± 5.3 11.2 ± 4.0 
f(mm2/IOO g) 10.9 ± 3.2 10.3 ± 2.3 8.6 ± 4.0* 
*p < 0.05, tp < 0.01, +p < 0.001 versus control values. §p < 0.01 versus 
baseline measurements in patients with aortic valve disease. A VD = aortic 
valve disease; CSALAD = cross-sectional area of left anterior descending 
coronary artery; CSALc• = cross-sectional area of left circumflex artery; 
CSARCA = cross-sectional area of right coronary artery; f = (CSALAD + 
CSALc.)I100 g of left ventricular muscle mass. 
evaluation or with control values. Left ventricular mass was 
significantly increased in patients with aortic valve disease 
with respect to control values; a further increase in left 
ventricular mass occurred at the follow-up examination. 
Coronary artery dimensions (Table 2, Fig. 2). In seven 
subjects in the control group, the right coronary artery was 
dominant, whereas the left coronary artery was dominant in 
three and a balanced type of distribution was present in two. 
Of the patients with aortic valve disease, right coronary 
dominance was present in four patients, left dominance in 
another four and a balanced distribution in two. These types 
of coronary dominance did not differ between the control 
group and patients with aortic valve disease. 
At baseline the proximal cross-sectional area of the left 
anterior descending and the left circumflex artery was sig-
nificantly larger in patients with aortic valve disease than in 
control subjects; however, after the follow-up period the 
dimensions of the left anterior descending and circumflex 
Figure 2. Coronary artery dimensions in control subjects and in 
patients with aortic valve disease (AVO) at baseline (B) and 
follow-up (F-U) evaluation. The cross-sectional area of the left 
anterior descending (LAD) and the left circumflex (LCX) coronary 
artery of the patients was increased significantly at baseline when 
compared with values in control subjects; both dimensions in-
creased further at follow-up evaluation. The size of the right 
coronary artery (RCA) did not change. 
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•• = p<O.01 , ... = p<O.OO1 vs. Controls. 
""= p<O.01 vs. AVO (8) 
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Table 3. Correlations Between Coronary Artery Dimensions and 
Hemodynamic Variables 
Left Coronary Right Coronary 
Cross-Sectional 
Artery (n = 32) Artery (n = 32) 
Area (mm2) p* r p* 
vs. LVSP (mm Hg) 0.58 <0.001 0.09 NS 
vs. LVEDP (mm Hg) 0.47 <0.01 0.19 NS 
vs. MPAP (mm Hg) 0.43 <0.05 0.47 <0.01 
vs. EF (%) -0.48 <0.01 -0.03 NS 
vs. LVEDV (mI) 0.66 <0.001 0.27 NS 
vs. LMM (g) 0.86 <0.001 0.28 NS 
vs. MCPP (mm Hg) 0.09 NS 0.25 NS 
vs. PWC (%) 0.08 NS 0.18 NS 
*By linear regression analysis. LVEDV = left ventricular end-diastolic 
volume; PWC = physical working capacity; other abbreviations as in Table I. 
arteries increased significantly with respect to baseline. The 
proximal cross-sectional area of the right coronary artery did 
not differ from control values at baseline or at follow-up. 
The index of the appropriateness of left coronary artery 
size per 100 g of left ventricular muscle mass was compara-
ble in patients with aortic valve disease at baseline and in 
control subjects (10.3 vs. 10.9 mm21100 g) but decreased 
significantly at the follow-up examination in the patients with 
valve disease (8.6 mm2/100 g). 
Correlations (Table 3). Correlations were calculated from 
all available data (n == 32) from control subjects as well as 
those from patients with aortic valve disease at baseline and 
at follow-up examination. There was a significant correlation 
between cross-sectional area of the left coronary artery and 
left ventricular peak systolic and end-diastolic pressure, 
mean pulmonary artery pressure, left ventricular end-
diastolic volume and left ventricular muscle mass (Fig. 3). 
Left coronary cross-sectional area was inversely related to 
ejection fraction (r == -0.48, p < 0.01) but did not correlate 
with mean coronary perfusion pressure or maximal work 
load in percent of the age-, gender- and height-corrected 
normal value. Cross-sectional area of the right coronary 
Figure 3. Correlation between left coronary artery cross-sectional 
area and left ventricular muscle mass (n = 32). The dashed lines 
represent the 95% confidence limits. Abbreviations as in Figure 2. 
n=32 
r = 0.86, pcO.OO1 
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Figure 4. Correlation between left coronary cross-sectional area per 
100 g of left ventricular muscle mass (LMM) and time period of 
follow-up evaluation in the patients with aortic valve disease (n = 
10). 
artery was correlated significantly only with mean pulmo-
nary artery pressure (r = 0.47, p < 0.01). A close inverse 
relation was present between the cross-sectional area of the 
left coronary artery per 100 g of left ventricular mass and 
the duration of the follow-up period (r == -0.65, p < 0.05, 
Fig. 4). 
Discussion 
Coronary artery enlargement consequent to left ven-
tricular hypertrophy has been shown to represent an adap-
tive mechanism to maintain blood flow and shear stress 
constant (22,23). Because coronary blood flow velocity is 
approximately the same in normal and hypertrophied ven-
tricles (22), the relation between coronary artery dimension 
and left ventricular muscle mass should also be constant. 
The data of the present study suggest that in the presence of 
moderate left ventricular hypertrophy the increase in coro-
nary artery dimensions is proportionate to the increase in left 
ventricular muscle mass because the index of the appropri-
ateness of left coronary cross-sectional area/l00 g of left 
ventricular muscle mass is comparable to that in control 
subjects (7,21,24,25). A further increase in left ventricular 
mass is accompanied by a further enlargement of coronary 
artery size; however, this increase is not proportionate to the 
increase in mass. 
Progression of left ventricular hypertrophy and coronary 
artery size. Marcus et al. (26) have demonstrated in dogs 
that the duration of left ventricular hypertrophy does not 
influence the severity of the decrease in coronary vasodilator 
reserve. However, in the same experimental study left 
ventricular mass was comparable at baseline and follow-up 
evaluation. In the present study the severity of aortic valve 
disease was mild to moderate, and ejection fraction was 
preserved at the time of the baseline evaluation. Ng et al. 
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(27) have demonstrated that, among patients with aortic 
valve stenosis, those with absent or mild left ventricular 
functional impairment are more likely to have progression of 
valve disease. In the present study all patients with aortic 
stenosis had a reduction in aortic valve area of >20% and an 
increase in the mean systolic pressure gradient of >40%. In 
patients with aortic regurgitation, the regurgitant fraction 
increased by >55% of the baseline value at follow-up eval-
uation. Thus, the severity of aortic valve disease increased 
in all patients in our study. The persistence and the increased 
severity of the overload condition led to a significant in-
crease in left ventricular mass and a decrease in systolic 
ejection performance. The inverse relation between these 
two variables has been previously described by Murakami et 
al. (28). 
In preoperative patients with aortic valve disease and left 
ventricular hypertrophy, it was shown that the dimensions of 
the left anterior descending and left circumflex arteries, but 
not of the right coronary artery, are increased. The present 
study confirms these findings in patients with mild to mod-
erate aortic valve disease who were not yet candidates for 
surgery at baseline examination. After a follow-up period of 
approximately 6 years, a significant increase in the severity 
of aortic valve disease was accompanied by a significant 
increase in left ventricular mass and a further increase in left 
coronary artery dimensions, whereas those of the right 
coronary artery did not change. Nevertheless, at follow-up 
evaluation the enlargement of the left coronary artery was 
not adequate to match the increased left ventricular mass; 
thus, the cross-sectional area per 100 g of left ventricular 
mass decreased significantly. This inadequate growth of the 
cross-sectional area was mainly due to the lower percent 
increase in left coronary artery dimensions with respect to 
the percent increase in left ventricular mass (21% vs. 27%, 
respectively, Fig. 5). 
Murray and Vatner (29) have demonstrated in dogs with 
severe right ventricular hypertrophy that the increase in 
right ventricular mass was not accompanied by a proportion-
ate increase of the total cross-sectional area of the coronary 
vasculature supplying the hypertrophied right ventricle. Sev-
eral other studies (7,21,24,25) reported a reduction of cross-
sectional area per 100 g of left ventricular mass in the 
hypertrophied left ventricle. Our findings suggest that the 
main determinant for the increase in coronary size is left 
ventricular hypertrophy. A previous report from oUf labora-
tory (7) has shown that in preoperative patients with aortic 
valve disease (360 g) the cross-sectional area of the left 
coronary artery per 100 g of left ventricular mass was 
reduced. After valve replacement and regression of left 
ventricular hypertrophy, the residually hypertrophied myo-
cardium (250 g) was supplied by a coronary artery that was 
enlarged but adequately sized with respect to left ventricular 
muscle mass (7). In the present study we observed the same 
pattern of variations; that is, coronary cross-sectional area 
per 100 g was normal in the presence of moderate left 
ventricular hypertrophy (left ventricular mass 269 g), 
(%) 50 NS 
40 
r-- p<0.05 --. 
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Figure 5. Percent changes in left ventricular mass (LMM) and 
cross-sectional area of the left (LC) and right (RCA) coronary artery 
at the follow·up evaluation (mean percent change and standard 
error). The percent change in left ventricular muscle mass was larger 
than the increase in cross·sectional area of the coronary arteries, 
although this difference reached statistical significance only for the 
right and not for the left coronary artery. 
whereas the increase in coronary artery dimensions was 
inappropriate when left ventricular hypertrophy was severe 
(left ventricular mass 339 g). 
Determinants of coronary artery size. The stimulating 
factor for increasing coronary cross-sectional area is not 
known. Several mechanisms are possible, such as coronary 
flow, myocardial hypertrophy or changes in microvascula-
ture. 
Coronary blood./low. Certainly coronary blood flow plays 
a major role. The continuous release of vasoactive sub-
stances, such as the endothelium-derived relaxing factor, 
increases with an increase in coronary blood flow and thus 
might stimulate the growth of coronary artery size ... is 
unknown if flow at rest or maximal flow is the stimulating 
factor for the increase in coronary artery size; flow at rest is 
increased in patients with myocardial hypertrophy, whereas 
maximal flow is normal and thus coronary flow reserve 
(maximal flow divided by resting flow) is decreased (3). 
If ./low at rest is the stimulating factor for the increase in 
coronary artery size, the growth of coronary arteries in 
patients with myocardial hypertrophy could be easily ex-
plained by the increase in flow at rest. However, the 
inadequate growth of the coronary arteries in patients with 
severe hypertrophy (decrease in coronary cross-sectional 
area per 100 g of muscle mass, Table 2) is difficult to explain 
but could be due to the relative decrease in coronary flow per 
100 g mass that has been observed in patients with severe 
aortic valve disease (30,31). 
If maximal flow is the stimulating factor for the increase 
in coronary artery size, then the reduction in coronary flow 
reserve in patients with severe myocardial hypertrophy 
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could explain the inadequate growth of the coronary arteries 
because maximal blood flow does not increase in proportion 
to left ventricular muscle mass (3) but remains more or less 
unchanged. The occurrence of myocardial ischemia with 
redistribution of coronary blood flow from the subendocar-
dium to the subepicardium (32-34) also could influence the 
growth of the coronary arteries by decreasing maximal flow 
to the subendocardium during exercise (32,33). 
Myocardial hypertrophy. Left ventricular hypertrophy 
plays an important role in the regulation of coronary blood 
flow and thus coronary artery size. The increase in cross-
sectional area of the coronary arteries in patients with severe 
aortic valve disease can be explained by the increase in 
coronary blood flow associated with myocardial hypertro-
phy. However, humoral (growth factors) or mechanical 
(stretch) stimuli could be responsible for the growth of the 
vascular smooth muscle; in other words, the growth factors 
causing left ventricular hypertrophy may also cause the 
increase in coronary artery size. An increase in the size of 
the epicardial coronary arteries was observed in postmortem 
hearts of patients with left ventricular hypertrophy (35,36). 
The relation between total heart weight and the diameters of 
the coronary arteries was found to be linear only up to a 
heart weight of 500 g (35). 
Microvasculature. Changes in the microvasculature 
(5,37) could lead to a decrease in coronary flow reserve 
and thus could be associated with an inadequate growth of 
the epicardial coronary arteries. However, it has been 
shown in patients with aortic valve disease (3) that coronary 
flow reserve tends to normalize after successful valve 
replacement, suggesting that the microvasculature is not 
altered but that hypertrophy is not associated with an 
appropriate increase in the cross-sectional area of the micro-
vascular bed. 
Angiogenesis has been observed in dogs (38) during 
long-term left ventricular hypertrophy that is sufficient to 
increase the cross-sectional area of the resistance vessels in 
proportion to the increase in left ventricular mass. However, 
in contrast to experimental studies in animals, no evidence 
exists that significant angiogenesis occurs in humans with 
left ventricular hypertrophy (39). 
Limitations of the study. It is important to consider other 
determinants of coronary artery size, such as physical work-
ing capacity, vessel dominance and coronary vasomotor 
tone. 
Physical working capacity has been reported to have a 
direct influence on coronary artery size (7). However, at the 
follow-up measurements there was an increase in cross-
sectional area of the left coronary artery and a decrease in 
physical working capacity. Thus, it is unlikely that the 
enlargement in coronary artery size was mediated by the 
physical working capacity. 
It is well known that a close relation exists between 
myocardial territory size and proximal coronary artery di-
ameter (40,41). However, in the present study coronary 
dominance was the same in control subjects and patients 
with aortic valve disease. Moreover, as in a previous study 
(7), after sUbgrouping the patients according to left or right 
coronary artery dominance, the same patterns of variations 
in the left and right coronary artery dimensions were ob-
served. 
Coronary vasomotor tone is another important factor that 
influences coronary artery dimensions. We did not evaluate 
coronary vasomotor tone, but it can be assumed that "over-
all" autonomic activity was similar because heart rate was 
the same in control subjects and patients with aortic valve 
disease (Table 1). However, we recognize that both humoral 
and endothelium-derived vasoactive factors may have varied 
among our patients. 
Conclusions. In patients with aortic valve disease, the 
progression of left ventricular hypertrophy is associated 
with an increase in left anterior descending and left 
circumflex dimensions, whereas the size of the right coro-
nary artery remains unchanged. Despite the enlargement of 
the left coronary artery dimension, the cross-sectional area 
of the left coronary artery per 100 g ofleft ventricular muscle 
mass decreases with progression of left ventricular hyper-
trophy. Hence, the increase in left coronary artery size 
appears to be inadequate to match the severity of left 
ventricular hypertrophy. 
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